Abstract
BACKGROUND The association between metabolic dysfunction–associated fatty liver disease (MAFLD) and chronic kidney disease (CKD) is unclear. OBJECTIVE This longitudinal cohort study aimed to test whether MAFLD plays an important role in the development of CKD. METHODS This cohort study included 41,246 participants who had undergone 3 or more health examinations from 2008 to 2015 at the People’s Hospital of Guangxi Zhuang Autonomous Region, China. Participants were categorized into 2 groups according to whether they presented with or without MAFLD. The occurrence of new-onset CKD was stated as either an estimated glomerular filtration rate of .05). CONCLUSIONS MAFLD plays an important role in the development of new incidents of CKD in the long run. CLINICALTRIAL Chinese Clinical Trial Registry ChiCTR2200058543; https://www.chictr.org.cn/showproj.html?proj=153109
All Related Versions

This publication has 38 references indexed in Scilit: